Product Information

NYSTATIN 100,000 UNIT/ML SUSP is a generic product labeled by PAI Holdings LLC, priced at $0.1476 per ML under NDC 00121086802. Its NADAC has been published 324 times since Sep 9, 2020.

FDA first approved this application on Jan 7, 2016. Its Orange Book therapeutic-equivalence code is AA.

NYSTATIN 100,000 UNIT/ML SUSP

NYSTATIN
$0.1476per ML

Strength

100000 [USP'U]/mL

Manufacturer

PAI Holdings LLC

NDC

00121086802

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NYSTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA203621

FDA Approved

1/7/2016

TE Code

AA

On Market Since

7/17/2020

Pharmacological Classes

Price Statistics

The NADAC for NYSTATIN 100,000 UNIT/ML SUSP has been published 324 times since Sep 9, 2020, and over the history we have for it it has declined 8.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1476 per ML
All-time high$0.1741 (Nov 13, 2024)
All-time low$0.0871 (Dec 21, 2022)
52-week high$0.1629
52-week low$0.1399
Median price$0.1371
Average price$0.1324
Largest weekly change+34.7% (Mar 22, 2023)
Weeks tracked324
Tracking sinceSep 9, 2020

Price History

1W

+3.2%

1M

+5.5%

3M

+5.3%

6M

+2.1%

1Y

-9.4%

3Y

+8.1%

5Y

+15.9%

All

-8.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NYSTATIN 100,000 UNIT/ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/ML SUSP, manufactured by PAI Holdings LLC, is $0.1476 per ML (NDC 00121086802), effective Nov 18, 2026.

How has the price of NYSTATIN 100,000 UNIT/ML SUSP changed over time?

Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has declined 8.1%. It has been tracked across 324 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/ML SUSP?

Since Sep 9, 2020, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has ranged from a low of $0.0871 (Dec 21, 2022) to a high of $0.1741 (Nov 13, 2024), with a median of $0.1371 per ML.

Are there cheaper alternatives to NYSTATIN 100,000 UNIT/ML SUSP?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/ML SUSP, is $0.0529 per ML — about 64% below NYSTATIN 100,000 UNIT/ML SUSP.

Who manufactures NYSTATIN 100,000 UNIT/ML SUSP?

NYSTATIN 100,000 UNIT/ML SUSP (NDC 00121086802) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.